Caitlyn Duffy

Hematology | Oncology
262 Danny Thomas Pl
Memphis, TN 38105

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications

Landscape Assessment to Characterize Baseline Access and Multilevel Barriers to IMProve Access to Chimeric Antigen Receptor T-Cell CD19 Therapy for Pediatric B-ALL (IMPACT study) Across Europe.

Landscape Assessment to Characterize Baseline Access and Multilevel Barriers to IMProve Access to Chimeric Antigen Receptor T-Cell CD19 Therapy for Pediatric B-ALL (IMPACT study) Across Europe.

Journal: JCO global oncology
Published: June 04, 2026

Safety and Tolerability of CAR T-Cell Therapy in Patients With End-Stage Kidney Disease on Hemodialysis: A Case Series.

Safety and Tolerability of CAR T-Cell Therapy in Patients With End-Stage Kidney Disease on Hemodialysis: A Case Series.

Journal: Clinical lymphoma, myeloma & leukemia
Published: December 30, 2025

Pediatric ALL Treatment Modifications in Low- and Middle-Income Countries: A Systematic Review.

Pediatric ALL Treatment Modifications in Low- and Middle-Income Countries: A Systematic Review.

Journal: JCO global oncology
Published: December 15, 2025

Landscape assessment to characterize baseline access and multilevel barriers to IMProve Access to CAR-T CD19 therapy (IMPACT study) across Europe.

Landscape assessment to characterize baseline access and multilevel barriers to IMProve Access to CAR-T CD19 therapy (IMPACT study) across Europe.

Journal: medRxiv : the preprint server for health sciences
Published: November 24, 2025

The Current State and Future Prospects for Artificial Intelligence in Dermatology.

The Current State and Future Prospects for Artificial Intelligence in Dermatology.

Journal: Dermatologic clinics
Published: October 15, 2025

Cardiovascular complications and their association with short- and long-term outcomes in patients with multiple myeloma undergoing chimeric antigen receptor T-cell therapy.

Cardiovascular complications and their association with short- and long-term outcomes in patients with multiple myeloma undergoing chimeric antigen receptor T-cell therapy.

Journal: British journal of haematology
Published: June 28, 2025

Measurable residual disease detection after CAR-T may predict response in patients with large B-cell lymphoma.

Measurable residual disease detection after CAR-T may predict response in patients with large B-cell lymphoma.

Journal: Blood advances
Published: January 02, 2025

Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy.

Cardiovascular Complications and Their Association With Short- and Long-Term Outcomes in Patients With Multiple Myeloma and Lymphoma Undergoing Chimeric Antigen Receptor T-Cell Therapy.

Journal: Circulation
Published: November 25, 2024

Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study.

Safety of CAR T-cell therapy for cancer in pre-existing autoimmune or inflammatory disease: a retrospective comparative cohort study.

Journal: The Lancet. Rheumatology
Published: November 08, 2024

Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.

Anti-CD19 Chimeric Antigen Receptor T-Cell Therapy for Richter Transformation: An International, Multicenter, Retrospective Study.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: March 29, 2024

Curing pediatric cancer: A global view. Examples from acute lymphoblastic leukemia.

Curing pediatric cancer: A global view. Examples from acute lymphoblastic leukemia.

Journal: Cancer
Published: March 29, 2024

A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma.

A real-world comparison of commercial-use axicabtagene ciloleucel and lisocabtagene maraleucel in large B-cell lymphoma.

Journal: Blood advances
Published: March 14, 2024
Showing 1-12 of 19

Last Updated: 09/26/2026